Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Nasim Mavaddat(MRC Epidemiology Unit), Christine L. Clarke(Memorial University of Newfoundland), Rowan T. Chlebowski(The Ohio State University), Volker Arndt(German Cancer Research Center), Michael Lush(University of Cambridge), Hiltrud Brauch(German Cancer Research Center), Jonathan P. Tyrer(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Thomas Brüning(Institute for Prevention and Occupational Medicine), Jose E. Castelao(Servicio Gallego de Salud), Sara Y. Brucker(University Children's Hospital Tübingen), Päivi Auvinen(University of Eastern Finland), Joe Dennis(University of Cambridge), Laura Fachal(University of Cambridge), Jamie Allen(University of Cambridge), Matthias W. Beckmann(Universitätsklinikum Erlangen), Thomas U. Ahearn(Harvard University), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Leslie Bernstein(National Cancer Institute), Myrto Barrdahl(German Cancer Research Center), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carl Blomqvist(University of Helsinki), Brian D. Carter(American Cancer Society), Michael Bremer(Medizinische Hochschule Hannover), Xin Yang(National Institutes of Health), Daniele Campa(University of Pisa), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Ting‐Huei Chen(Université Laval), Adam R. Brentnall(Queen Mary University of London), Muriel A. Adank(The Netherlands Cancer Institute), Laura E. Beane Freeman(National Cancer Institute), Kristan J. Aronson(Queen's University), Stephen J. Chanock(National Cancer Institute), Qin Wang(University of Cambridge), Andrew Lee(University of Cambridge), Hans Christiansen(Medizinische Hochschule Hannover), Barbara Burwinkel(German Cancer Research Center), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Kristiina Aittomäki(University of Helsinki), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Ian W. Brock(University of Sheffield), Marina Bermisheva(Russian Academy of Sciences), Manjeet K. Bolla(University of Cambridge), Angela Brooks‐Wilson(BC Cancer Agency)
Cited by 1,179
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k